Hi BHS,
There was a few but it was mainly aimed at Retail Investors to gain additional exposure and to share the Admedus story. I know I am biased but we were head and shoulders above the other companies in terms of presentation, revenue achieved and forecast, IP moat, global growth, opportunity, margins, and targets laid out.
Wayne had plenty of scheduled dedicated Fund Managers meetings planned.
This was “additional” to the Fund Managers roadshow and a bonus for us retail shareholders.
Financial News Network Presentation, page-20
-
- There are more pages in this discussion • 85 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.19 |
Change
-0.300(2.40%) |
Mkt cap ! $262.3M | |||
| Open | High | Low | Value | Volume |
| $12.49 | $12.50 | $11.89 | $101.9K | 8.268K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 309 | $12.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.19 | 259 | 4 |
View Market Depth
| Last trade - 12.16pm 30/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |